These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25625806)

  • 1. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).
    Kokudo N; Hasegawa K; Akahane M; Igaki H; Izumi N; Ichida T; Uemoto S; Kaneko S; Kawasaki S; Ku Y; Kudo M; Kubo S; Takayama T; Tateishi R; Fukuda T; Matsui O; Matsuyama Y; Murakami T; Arii S; Okazaki M; Makuuchi M
    Hepatol Res; 2015 Jan; 45(2):. PubMed ID: 25625806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.
    Kokudo N; Takemura N; Hasegawa K; Takayama T; Kubo S; Shimada M; Nagano H; Hatano E; Izumi N; Kaneko S; Kudo M; Iijima H; Genda T; Tateishi R; Torimura T; Igaki H; Kobayashi S; Sakurai H; Murakami T; Watadani T; Matsuyama Y
    Hepatol Res; 2019 Oct; 49(10):1109-1113. PubMed ID: 31336394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
    Hasegawa K; Takemura N; Yamashita T; Watadani T; Kaibori M; Kubo S; Shimada M; Nagano H; Hatano E; Aikata H; Iijima H; Ueshima K; Ohkawa K; Genda T; Tsuchiya K; Torimura T; Ikeda M; Furuse J; Akahane M; Kobayashi S; Sakurai H; Takeda A; Murakami T; Motosugi U; Matsuyama Y; Kudo M; Tateishi R;
    Hepatol Res; 2023 May; 53(5):383-390. PubMed ID: 36826411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
    Kudo M; Kawamura Y; Hasegawa K; Tateishi R; Kariyama K; Shiina S; Toyoda H; Imai Y; Hiraoka A; Ikeda M; Izumi N; Moriguchi M; Ogasawara S; Minami Y; Ueshima K; Murakami T; Miyayama S; Nakashima O; Yano H; Sakamoto M; Hatano E; Shimada M; Kokudo N; Mochida S; Takehara T
    Liver Cancer; 2021 Jun; 10(3):181-223. PubMed ID: 34239808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
    Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y; Okusaka T; Miyayama S; Tsuchiya K; Ueshima K; Hiraoka A; Ikeda M; Ogasawara S; Yamashita T; Minami T; Yamakado K;
    Liver Cancer; 2014 Oct; 3(3-4):458-68. PubMed ID: 26280007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).
    Arii S; Sata M; Sakamoto M; Shimada M; Kumada T; Shiina S; Yamashita T; Kokudo N; Tanaka M; Takayama T; Kudo M
    Hepatol Res; 2010 Jul; 40(7):667-85. PubMed ID: 20633193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update.
    Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology
    Hepatol Res; 2020 Jul; 50(7):791-816. PubMed ID: 32343477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline.
    Izumi N
    Oncology; 2010 Jul; 78 Suppl 1():78-86. PubMed ID: 20616588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.
    Song P; Tang W; Hasegawa K; Kokudo N
    Drug Discov Ther; 2014 Apr; 8(2):64-70. PubMed ID: 24815580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease.
    Renzulli M; Golfieri R;
    J Gastroenterol Hepatol; 2016 Jan; 31(1):69-80. PubMed ID: 26312574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis.
    Yamaguchi K; Okusaka T; Shimizu K; Furuse J; Ito Y; Hanada K; Shimosegawa T; Okazaki K;
    Pancreas; 2017; 46(5):595-604. PubMed ID: 28426492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update.
    Kudo M; Matsui O; Izumi N; Kadoya M; Okusaka T; Miyayama S; Yamakado K; Tsuchiya K; Ueshima K; Hiraoka A; Ikeda M; Ogasawara S; Yamashita T; Minami T;
    Oncology; 2014; 87 Suppl 1():22-31. PubMed ID: 25427730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.
    Lee JM; Park JW; Choi BI
    Dig Dis; 2014; 32(6):764-77. PubMed ID: 25376295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines.
    Song P
    Biosci Trends; 2013 Oct; 7(5):250-2. PubMed ID: 24241176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis.
    Asahina Y;
    Hepatol Res; 2020 Jul; 50(7):775-790. PubMed ID: 32298527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update.
    Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology
    Hepatol Res; 2020 Aug; 50(8):892-923. PubMed ID: 32343469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.